Device evaluation: the device evaluation of the evolution® esophageal controlled-release stent -fully covered could not be completed as the device or photographic evidence of the device was not returned for evaluation.This file was created in response to a pmcf study ¿(b)(4)¿ to capture ¿stent migration confirmed with endoscopy¿ manufacturing records: prior to distribution all devices are subjected to a visual inspection and functional inspection to ensure device integrity.Manufacturing records review could not be completed as the lot number is unknown.Review historical data: historical data was not reviewed as the lot number is unknown.Instructions for use and/label : the instructions for use, ifu0061 which accompanies this device, states ¿additional complications that can occur in conjunction with upper gi endoscopy include, but are not limited to: stent misplacement and/or migration; tumor ingrowth or over growth; oesophageal ulceration and erosion; nausea chest or retrosternal pain; foreign body sensation ;food bolus impaction; gas bloat; sensitivity to metal components; fistula involving trachea, bronchi or pleural space; intestinal obstruction; aorta and arterioesphageal fistula; erosion or perforation of stent into adjacent vascular structures.¿¿ there is evidence to suggest that the customer did not follow the instructions for use.Therefore additional complaint file (b)(4) was raised which captures the user error of using supplementation fixation clips during stent placement.Image review: an image was not returned for evaluation.Root cause analysis: a definitive root cause could not be determined from the available information.A possible root cause could be attributed to patient condition, as per instructions for use, stent migration is listed as a potential complication that can occur in conjunction with upper gi endoscopy.Confirmation of complaint: complaint is confirmed based on customer and/or rep testimony.Corrective action/ correction: complaints of this nature will continue to be monitored for potential emerging trends.Summary of investigation: according to the pmcf study 14 days post placement stent migrated distally to stomach.Confirmed quantity of 1 device, confirmed used.The patient did not experience any adverse effects due to this occurrence.The study stent was repositioned.Investigation findings conclude a definitive root cause was established.A possible root cause could be attributed to patient condition.
|